Document is current
Any future updates will be listed below
-
Authors
Nofi, Colleen P.
Prince, Jose M.
Brewer, Mariana R.
Aziz, Monowar
Wang, Ping https://orcid.org/0000-0002-1557-0394
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01GM129633)
Foundation for the National Institutes of Health (U01AI170018)
Foundation for the National Institutes of Health (R35GM118337)
Foundation for the National Institutes of Health (R01HL076179)
Foundation for the National Institutes of Health (R01AA028947)
Foundation for the National Institutes of Health (U01AI170018)
- License Information
-
More Information
Article History
Received: 20 May 2024
Accepted: 11 September 2024
First Online: 20 September 2024
Declarations
:
: Human stool samples were studied under the approval of Institutional Review Board (Northwell Health IRB No. 19-0981). All animal studies were performed under the approval of the Institutional Animal Care and Use Committee of the Feinstein Institutes for Medical Research (Protocol No. 2023–005).
: Yes.
: The authors (CN, MA, and PW) are inventors of the pending PCT application on “A chimeric molecule to treat septic patients”; EFS ID: 47240580; Application No.: 63433789. Other authors report no financial competing interests.
